J Korean Med Assoc Search

CLOSE


J Korean Med Assoc > Volume 46(9); 2003 > Article
Joh: Indication and Prognosis of Liver Transplantation

Abstract

Liver transplantation is the only hope for patients with terminal liver cirrhosis. Liver transplantation has evolved rapidly over the past two dacades, and its indication has been expanded. The most common indication of liver transplantation is terminal liver cirrhosis from any cause (hepatitis B, hepatitis C/non-A,non-B, alcoholic, autoimmune and others). Other indications are hepatic neoplasm, fulminant hepatic failure, biliary atresia, primary biliary cirrhosis, primary sclerosing cholangitis, and some metabolic diseases. Liver transplantation can be always considered as an option for life-saving treatment in case of failure of liver function. So we should consider absolute contraindications of liver transplantation : active substance abuse, unstableactive cardiopulmonary disease, incurable extrahepatic malignancy, active uncontrolled and untreatable sepsis, active HIV infection (unresponsive to treatment), inadequate social support, extreme psychosocial dysfunction, and extensive vascular thrombosis precluding liver transplantation. For improved survival and better prognosis in cases of liver transplantation much attention is needed for careful long-term follow-up and surveillance for cardiovascular risk factors, de novo malignancy, and metabolic factors.

References

1. Seaberg EC, Belle SH, Beringer KC, et al. Liver transplantation in the Uinted States from 1987-1998 : update result from the Pitt-UNOS liver transplantation registry. Clin Transpl 1998;17-37.

2. Todo S, Demetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus related liver disease. Hepatology 1991;13:619-626.

3. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with hepatitis B surface antigen. N Engl J Med 1993;329:1842-1847.

4. Terrault NA, Zhou S, Combs C, et al. Prophylaxis in liver transplant recipients using a fixed dose of hepatitis B immunoglobulin. Hepatology 1996;24:1327-1333.

5. McGory RW, Ishtani MC, Oliviera WM, et al. Improved outcome of orthotopic liver transplantation of chronic hepatitis B cirrhosis with aggressive passive immunization. Transplantation 1996;61:1358-1364.

6. Bismuth H, Majno PE, Adem R. Liver transplantation for hepatocellular carcinoma. Semin liver Dis 1999;19:311.

7. Kaihara S, Kiuchi T, Tanake K, et al. Living donor liver transplantation for hepatocellular carcinoma. Transplantation 2003;75:3 Suppl. S37-S40.

8. Wright TL, Donegan E, Hsu HH, et al. Recurrence and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology 1992;103:317-322.

9. Ringe B, Pichmayr R, Wittekind C, et al. Surgical treatment of hepatocellular carcinomas : experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270-285.

10. Esquivel CO, Van Thiel DH, Demetris AJ, et al. Transplantation for primary biliary cirrhosis. Gastroenterology 1998;94:1207-1216.

Table 1
jkma-46-845-i001-l.jpg
Table 2
jkma-46-845-i002-l.jpg
Table 3
jkma-46-845-i003-l.jpg


ABOUT
ARTICLE CATEGORY

Browse all articles >

ARCHIVES
FOR CONTRIBUTORS
Editorial Office
37 Ichon-ro 46-gil, Yongsan-gu, Seoul
Tel: +82-2-6350-6562    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2024 by Korean Medical Association.

Developed in M2PI

Close layer
prev next